Works matching DE "EPIDERMAL growth factor receptors"

Results: 5000
    1
    2
    3
    4

    Treatment and Outcomes in Advanced Gastroesophageal Adenocarcinoma in the Pre-Immunotherapy Era Based on the Spanish AGAMENON-SEOM Registry.

    Published in:
    Cancers, 2025, v. 17, n. 13, p. 2164, doi. 10.3390/cancers17132164
    By:
    • Jimenez-Fonseca, Paula;
    • Carmona-Bayonas, Alberto;
    • Álvarez-Cañada, Jaime;
    • Storfer-Isser, Amy;
    • Martin-Richard, Marta;
    • Sauri, Tamara;
    • Cano, Juana María;
    • Martínez Moreno, Elia;
    • Pérez-Wert, Pablo;
    • López, Javier;
    • Garcia Navalon, Francisco;
    • Gómez-González, Lucía;
    • Ruiz Martín, Maribel;
    • Rupérez Blanco, Ana Belén;
    • López-López, Flora;
    • Roncancio-Díaz, Emilse;
    • Corbacho, Belén;
    • Mateo, Marta;
    • Anguita-Alonso, Paloma;
    • Gallego Plazas, Javier
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Risk factors of bone metastasis in lung adenocarcinoma.

    Published in:
    BMC Pulmonary Medicine, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12890-025-03702-0
    By:
    • Cao, Zhongnian;
    • Zheng, Rong;
    • Li, Jing;
    • Wang, Xuejuan;
    • Ding, Chao;
    • Zhang, Fan;
    • Geng, Jianhua;
    • Wei, Zhengmao;
    • Fan, Rong
    Publication type:
    Article
    33
    34

    A genome-wide in vivo CRISPR activation screen identifies BACE1 as a therapeutic vulnerability of lung cancer brain metastasis.

    Published in:
    Science Translational Medicine, 2025, v. 17, n. 805, p. 1, doi. 10.1126/scitranslmed.adu2459
    By:
    • Chafe, Shawn C.;
    • Zhai, Kui;
    • Aghaei, Nikoo;
    • Miletic, Petar;
    • Huang, Zhi;
    • Brown, Kevin R.;
    • Mobilio, Daniel;
    • Young, Daniel;
    • Suk, Yujin;
    • Grewal, Shan;
    • McKenna, Dillon;
    • Alizada, Zahra;
    • Kieliszek, Agata M.;
    • Lam, Fred C.;
    • Escudero, Laura;
    • Huang, Qian;
    • Huebner, Ariana;
    • Lu, Jack;
    • Ang, Patrick;
    • Anand, Alisha
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Palazestrant, a novel oral Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD), in patients with ER+/HER2− advanced or metastatic breast cancer: phase 1/2 study results.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02049-y
    By:
    • Hamilton, Erika P.;
    • Patel, Manish R.;
    • Borges, Virginia F.;
    • Meisel, Jane L.;
    • Okera, Meena;
    • Alemany, Carlos A.;
    • Pluard, Timothy J.;
    • Wesolowski, Robert;
    • Sabanathan, Dhanusha;
    • Miller, Kathy D.;
    • Conlin, Alison K.;
    • McCarthy, Nicole;
    • Shaw, Morena;
    • Tonda, Margaret;
    • Shilkrut, Mark;
    • Lin, Nancy U.
    Publication type:
    Article
    50